1-3 of 3
I Zimmerman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tyrosine Kinase Inhibitor (TKI) Combination Scheduling Impacts Secondary FLT3 Tyrosine Kinase Domain (TKD) Mutation Profiles in a Xenograft Model of FLT3-ITD+ Acute Myeloid Leukemia (AML)

Jolieke G van Oosterwijk, PhD, Eric I Zimmerman, PhD, Yong-Dong Wang, PhD, Shelley Orwick, Aksana Vasilyeva, PhD, Katja Schuster, PhD, Abhijit Ramachandran, PhD, Hiroto Inaba, MD PhD, Sharyn D Baker, PharmD, PhD
Journal: Blood
Blood (2014) 124 (21): 3620.
https://doi.org/10.1182/blood.V124.21.3620.3620
Published: 2014
Journal Articles

Crenolanib is active against models of drug-resistant FLT3-ITD−positive acute myeloid leukemia

Eric I. Zimmerman, David C. Turner, Jassada Buaboonnam, Shuiying Hu, Shelley Orwick, Michael S. Roberts, Laura J. Janke, Abhijit Ramachandran, Clinton F. Stewart, Hiroto Inaba, Sharyn D. Baker
Journal: Blood
Blood (2013) 122 (22): 3607–3615.
https://doi.org/10.1182/blood-2013-07-513044
Published: 2013
Includes: Supplemental data
Journal Articles

Evaluation of extracorporeal alkylation of red cells as a potential treatment for sickle cell anemia

S Charache, R Dreyer, I Zimmerman, CK Hsu
Journal: Blood
Blood (1976) 47 (3): 481–488.
https://doi.org/10.1182/blood.V47.3.481.481
Published: 1976